James offers over 17 years’ experience within the Life Science Industry working in varying roles including Primary Care and Secondary Care Sales, Regional Management, Market Access Manager, Service Development, Project Management and Consultancy.

James has been fortunate to work with some amazing companies and products in a broad range of disease areas covering primary / secondary care medicines, high cost drugs, rare diseases, medical devices and digital healthcare solutions.

Before transitioning into consultancy James began his career with MSD where he launched Sitagliptin (Januvia) and as a Market Access Manger had significant success in the South West of England.  As well as Market Access he spent time as a Regional Business Manager in Women’s Health and latterly also manged the Primary Care Market Access Team

After 8 ½ years at MSD James moved to Quintiles, where as an NHS Commercial Director worked on Market Access projects with Novartis, Sunovian Pharmaceuticals, Novo Nordisk, Gilead Sciences and AstraZeneca, where he expanded his knowledge of client based solutions in Market Access.

Moving on from Quintiles in 2015 James spent several years at Abbott Diabetes Care developing market access for the innovative new diabetes technology Freestyle Libre.  In this time James delivered numerous successful outcomes across the South of England positioning Libre and its digital based healthcare solutions to improve patient care in diabetes.

After leaving Abbott James worked on an 18 month project as a Cardiovascular Pathway Manager for Bayer.  Key to this role was developing effective patient pathway solutions, with the NHS, to support the uptake of new licence indications for Bayer’s Anti-coagulation medicine Rivaroxaban (Xarleto)

In 2019 James moved to IQVIA where he took up the role of a Market Access Manger which involved multiple functions including; field based payer engagement, Pharma / Med-Tech Consultancy and Business Development. Working on projects with multiple clients including; Novartis & Trudell Medical, James delivered project successes, most significantly in writing a UK value dossier and introducing a CCG funded high cost drug into the NHS QIPP programme.

In 2020, inspired by the knowledge and skills gained from the Life Science Industry, James set up his own Market Access and Service Development Consultancy called Insights2health Ltd.  Through delivering successful project outcomes for Takeda, Gilead Sciences, Medicom Healthcare, Arvelle Therapeutics and AstraZeneca Insights2health Ltd. has also partnered in projects with Morph Consultancy, UKFRN, StarOutico, Orchardwise Limited, Fish Pharma and now most recently Networking Health.